Dr Manu Shankar-Hari
Professor of Critical Care Medicine – Guy’s and St Thomas’ NHS Foundation Trust
UK. Principal Investigator – School of Immunology and Microbial Sciences, King’s College London.
15:45PM – 16:05PM – Sepsis Survivor Prognosis Score – Informing recovery prospects for Sepsis Survivors
Manu Shankar-Hari is Professor of Critical Care Medicine at Guy’s and St Thomas’ Hospital and leads a translational research group at King’s College London.
Shankar-Hari group’s research explores ways to improve outcomes in adult critically ill patients with sepsis and with ARDS, by linking the illness immunobiology with novel interventional trial designs.
Our lab has the following focussed research themes
- Immunobiology: Explore adaptive immune system changes during sepsis, during ARDS and longer-term in patients who survive sepsis.
- Epidemiology and Stratified medicine: We use early-phase randomised controlled trials, cohort studies, systematic reviews and large clinical trial datasets to identify treatable traits based on dominant biological mechanisms.
- COVID-19 research focuses on clinical trials, translational immunology and children with PIMS-TS illness: Translational immunology in adults focuses on how the immune system responses are influenced by treatment with convalescent plasma and recombinant interleukin-7 in the respective clinical trials.
For further details, please see webpage: https://www.kcl.ac.uk/research/shankar-hari-group